Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy

AAPS PharmSciTech

Volumn 15, Issue 1, 2014, Pages 213-222

  Ding, Dawei ^a   Tang, Xiaolei ^a   Cao, Xiaoli ^a   Wu, Jinhui ^a   Yuan, Ahu ^a   Qiao, Qian ^a   Pan, Jing ^b   Hu, Yiqiao ^a  

^a NANJING UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

human serum albumin; nanoparticles; paclitaxel; self assembly; targeted drug delivery

Indexed keywords

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MALE; MCF-7 CELLS; MICE; MICE, INBRED ICR; NANOMEDICINE; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; SERUM ALBUMIN; SOLUTIONS;

EID: 84893789928     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-013-0041-3     Document Type: Article

References (42)

1. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007 Dec;2(12):751-60.
2. MacKay JA, Chen M, McDaniel JR, Liu W, Simnick AJ, Chilkoti A. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat Mater. 2009 Dec;8(12):993-9.
3. Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008 Mar 1;14(5):1310-6.
4. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer. 2006 Sep;6(9):688-701.
5. Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target. 2007 Aug-Sep;15(7-8):457-64. PubMed PMID: 17671892.
6. Lee CC, MacKay JA, Frechet JM, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol. 2005 Dec;23(12):1517-26.
7. Gratton SE, Pohlhaus PD, Lee J, Guo J, Cho MJ, Desimone JM. Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. J Control Release. 2007 Aug 16;121(1-2):10-8.
8. Pan J, Chan SY, Lee WG, Kang L. Microfabricated particulate drug-delivery systems. Biotechnol J. 2011 Dec;6(12):1477-87.
9. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov. 2003 May;2(5):347-60.
10. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005 Mar;5(3):161-71.
11. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008 Sep;7(9):771-82.
12. Xiao K, Luo J, Fowler WL, Li Y, Lee JS, Xing L, et al. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer. Biomaterials. 2009 Oct;30(30):6006-16.
13. Rihova B. Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers. Adv Drug Deliv Rev. 1996;21(2):157-76.
14. Maham A, Tang Z, Wu H, Wang J, Lin Y. Protein-based nanomedicine platforms for drug delivery. Small. 2009 Aug 3;5(15):1706-21.
15. Fung SY, Yang H, Bhola PT, Sadatmousavi P, Muzar E, Liu M, et al. Self-assembling peptide as a potential carrier for hydrophobic anticancer drug ellipticine: complexation, release and in vitro delivery. Adv Funct Mater. 2009;19(1):74-83.
16. Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012 Jan 30;157(2):168-82.
17. McDaniel JR, Callahan DJ, Chilkoti A. Drug delivery to solid tumors by elastin-like polypeptides. Adv Drug Deliv Rev. 2010 Dec 30;62(15):1456-67.
18. Desai N. Nab technology: a drug delivery platform utilizing endothelial gp60 receptor-based transport and tumour-derived SPARC for targeting. Drug Delivery Report 16th edition; 2007. p. 37-41.
19. Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res. 2006 Feb 15;12(4):1317-24.
20. Damascelli B, Cantu G, Mattavelli F, Tamplenizza P, Bidoli P, Leo E, et al. Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007): phase II study of patients with squamous cell carcinoma of the head and neck and anal canal: preliminary evidence of clinical activity. Cancer. 2001 Nov 15;92(10):2592-602.
21. Bale AS, Barone Jr S, Scott CS, Cooper GS. A review of potential neurotoxic mechanisms among three chlorinated organic solvents. Toxicol Appl Pharmacol. 2011 Aug 15;255(1):113-26.
22. Xu R, Fisher M, Juliano RL. Targeted albumin-based nanoparticles for delivery of amphipathic drugs. Bioconjug Chem. 2011 May 18;22(5):870-8.
23. Gong J, Huo M, Zhou J, Zhang Y, Peng X, Yu D, et al. Synthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micelles. Int J Pharm. 2009 Jul 6;376(1-2):161-8.
24. Zhao Q, Chen W, Chen Y, Zhang L, Zhang J, Zhang Z. Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjug Chem. 2011 Mar 16;22(3):346-52.
25. Dreher MR, Simnick AJ, Fischer K, Smith RJ, Patel A, Schmidt M, et al. Temperature triggered self-assembly of polypeptides into multivalent spherical micelles. J Am Chem Soc. 2008 Jan 16;130(2):687-94.
26. Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine. 2006 Mar;2(1):8-21.
27. Hu Y, Wu J, Ding D, Gong G, Tang X, Tong C, et al., inventors; WO Patent WO/2011/017,835, assignee. Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding. 2011.
28. Yang JT, Wu CS, Martinez HM. Calculation of protein conformation from circular dichroism. Methods Enzymol. 1986;130:208-69.
29. Villoutreix BO, Garcia de Frutos P, Lovenklev M, Linse S, Fernlund P, Dahlback B. SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations. Proteins. 1997 Dec;29(4):478-91. PubMed PMID: 9408945.
30. Zhu Z, Li Y, Li X, Li R, Jia Z, Liu B, et al. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo. J Control Release. 2010 Mar 19;142(3):438-46.
31. Yu DH, Lu Q, Xie J, Fang C, Chen HZ. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials. 2010 Mar;31(8):2278-92.
32. Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm. 2002 Feb 21;233(1-2):51-9.
33. Frei E. Albumin binding ligands and albumin conjugate uptake by cancer cells. Diabetol Metab Syndr. 2011;3(1):11.
34. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature. 1992 Jul 16;358(6383):209-15.
35. Galantini L, Leggio C, Konarev PV, Pavel NV. Human serum albumin binding ibuprofen: a 3D description of the unfolding pathway in urea. Biophys Chem. 2010 Apr;147(3):111-22.
36. Wang J, Sui M, Fan W. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab. 2010 Feb;11(2):129-41.
37. Venkatraman SS, Ma LL, Natarajan JV, Chattopadhyay S. Polymer- and liposome-based nanoparticles in targeted drug delivery. Front Biosci (Schol Ed). 2010;2:801-14.
38. Singh R, Lillard Jr JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009 Jun;86(3):215-23.
39. Liu X, Lei L, Hou JW, Tang MF, Guo SR, Wang ZM, et al. Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application. J Mater Sci: Mater Med. 2011 Feb;22(2):327-37.
40. Lu Z, Yeh TK, Tsai M, Au JL, Wientjes MG. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res. 2004 Nov 15;10(22):7677-84.
41. Framson PE, Sage EH. SPARC and tumor growth: where the seed meets the soil? J Cell Biochem. 2004 Jul 1;92(4):679-90.
42. Peng L, Liu R, Marik J, Wang X, Takada Y, Lam KS. Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging. Nat Chem Biol. 2006 Jul;2(7):381-9.